These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36132143)

  • 1. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs.
    Zhang L; Wang C; Lu X; Xu X; Shi T; Chen J
    Front Oncol; 2022; 12():927524. PubMed ID: 36132143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLX6-AS1: A Long Non-coding RNA With Oncogenic Features.
    Ghafouri-Fard S; Najafi S; Hussen BM; Ganjo AR; Taheri M; Samadian M
    Front Cell Dev Biol; 2022; 10():746443. PubMed ID: 35281110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma.
    Long J; Bai Y; Yang X; Lin J; Yang X; Wang D; He L; Zheng Y; Zhao H
    Cancer Cell Int; 2019; 19():90. PubMed ID: 31007608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
    J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
    Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.
    Zheng Q; Gu X; Yang Q; Chu Q; Dai Y; Chen Z
    Clin Chim Acta; 2021 Jun; 517():1-8. PubMed ID: 33607068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising long noncoding RNA DLX6-AS1 in malignant tumors.
    Xue C; Lv L; Jiang J; Li L
    Am J Transl Res; 2020; 12(12):7682-7692. PubMed ID: 33437353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially expressed non-coding RNAs and their regulatory networks in liver cancer.
    Moldogazieva NT; Zavadskiy SP; Astakhov DV; Sologova SS; Margaryan AG; Safrygina AA; Smolyarchuk EA
    Heliyon; 2023 Sep; 9(9):e19223. PubMed ID: 37662778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
    Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
    J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy.
    Wu Y; Wang L; Wang X; Zhao Y; Mao A; Zhang N; Zhou J; Pan Q; Zhu W; Wang L
    Cancer Cell Int; 2021 Sep; 21(1):464. PubMed ID: 34488748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Omics Integration-Based Prioritisation of Competing Endogenous RNA Regulation Networks in Small Cell Lung Cancer: Molecular Characteristics and Drug Candidates.
    Wang XJ; Gao J; Yu Q; Zhang M; Hu WD
    Front Oncol; 2022; 12():904865. PubMed ID: 35860558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of a Panel of Transcripts Identified From a Small Sample Size and Construction of RNA Networks in Hepatocellular Carcinoma.
    Sheng Z; Wang X; Xu G; Shan G; Chen L
    Front Genet; 2019; 10():431. PubMed ID: 31156698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma.
    Han TS; Hur K; Cho HS; Ban HS
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
    Li X; Zhang H; Wu X
    Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic identification of aberrant non-coding RNAs and their mediated modules in rotator cuff tears.
    Zhang Y; Chen J; He S; Xiao Y; Liu A; Zhang D; Li X
    Front Mol Biosci; 2022; 9():940290. PubMed ID: 36111133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.